Safety and Immunogencity of H7N9 Influenza Antigen With 2 Adjuvant Formulations in Healthy Adults in Brazil

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2018
The overall aim of this study is to evaluate the safety, immunogenicity and dose sparing effects of H7N9 influenza antigen formulated with 2 different adjuvants .
Epistemonikos ID: 2539f7323008d54f243327349a6a82788836c818
First added on: May 21, 2024